Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $22.3 million.

  • Rapid Micro Biosystems' Short-term Investments fell 4250.28% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year decrease of 4250.28%. This contributed to the annual value of $33.8 million for FY2024, which is 5009.3% down from last year.
  • Rapid Micro Biosystems' Short-term Investments amounted to $22.3 million in Q3 2025, which was down 4250.28% from $12.9 million recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Short-term Investments peaked at $99.7 million during Q1 2022, and registered a low of $1.3 million during Q2 2021.
  • For the 5-year period, Rapid Micro Biosystems' Short-term Investments averaged around $49.4 million, with its median value being $47.9 million (2024).
  • Per our database at Business Quant, Rapid Micro Biosystems' Short-term Investments surged by 734250.79% in 2022 and then tumbled by 6013.52% in 2025.
  • Rapid Micro Biosystems' Short-term Investments (Quarter) stood at $15.1 million in 2021, then surged by 439.93% to $81.6 million in 2022, then fell by 16.93% to $67.8 million in 2023, then crashed by 50.09% to $33.8 million in 2024, then plummeted by 34.06% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $12.9 million for Q2 2025, and $22.8 million during Q1 2025.